Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

October 1, 2024

New Haven-based digital healthcare firm Wellinks acquires San Francisco tech company

Contributed A passive patient monitor made by Spire Health.
By David Krechevsky

Wellinks Inc., a New Haven-based digital healthcare firm, said Monday it has acquired San Francisco-based medical device and data company Spire Health in a non-cash transaction. 

As part of the agreement, Rich Wilmot, a partner with Spire’s majority investor Gilde Healthcare, will join Wellinks’ board of directors. 

Wellinks said the deal will merge Spire’s patient monitoring technology with Wellinks cardiopulmonary care model, creating a first-of-its-kind fully integrated “predictive patient care” company.

Formed in 2019 through a merger with Convexity Scientific Inc., Wellinks is located at 85 Willow Street in New Haven. The company develops virtual tools to treat chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF).

Wellinks raised $25 million in a Series C funding round in 2021 to fund clinical research and development and expand marketing. It has raised a total of $26.1 million overall.

Kevin Rakin, Wellinks chairman and managing partner of HighCape Capital, said combining the companies positions Wellinks “at the forefront of applying predictive analytics to the clinical care of cardiopulmonary patients.”
 
COPD and CHF affect 14.2 million and 6.5 million people, respectively, in the United States.
Predictive patient care utilizes advanced predictive analytics to equip providers with information and clinical interventions designed to identify potential exacerbations and costly complications from these conditions before they rise to the level of emergency care and/or hospitalization. 

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF